HYBRID PEPTIDES: A NEW CLINICAL FRONTIER

Chimera molecules represent a rapidly evolving domain in therapeutic research, offering a novel method to address previously difficult illnesses. Such engineered structures integrate multiple protein motifs, allowing for optimized binding to multiple sites and potentially overcoming medicinal tol